Atlas FDA

Organ Care System (OCS™) Lung System

FDA premarket approval P160013/S013 · decided 2023-06-28

Approval details

PMA number
P160013
Supplement
S013
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Trade name
Organ Care System (OCS™) Lung System
Generic name
Normothermic machine perfusion system for the preservation of standard criteria donor lungs prior to transplantation
Applicant
TransMedics, Inc.
Date received
2023-05-15
Decision date
2023-06-28
Days to decision
44 days
Decision code
APPR
Product code
QBA
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Andover, MA
Statement
Approval of the revised protocol for the post-approval study (PAS) protocol.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
OCS Heart Leukocyte Depleting Filter (K231362)TransMedics, Inc.2023-10-31
OCS Lung Donor Flush Set (K222535)TransMedics, Inc.2022-11-18
OCS Lung Solution (K211314)TransMedics, Inc.2021-07-29